If you liked this article you might like

Cramer's 'Mad Money' Recap: Now, the Focus Is Earnings

Investors Shun Bed Bath & Beyond, Walgreens Growth Deals

Cost Plus Stock Hits New 52-Week High (CPWM)

Bed Bath & Beyond Deal Shows Right Kind of Risk Taking